Physician profile
Harvey Slusky
NPI 1700816790
$26,298.29
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $527 · 2021: $141 · 2022: $192 · 2023: $2,570 · 2024: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $22K · Travel and Lodging: $1,534 · Food and Beverage: $1,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $22,458.53 |
| Travel and Lodging | $1,534.19 |
| Food and Beverage | $1,317.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25,272.59 | 2022-2024 | Micra, Closurefast, Hawkone |
| Medicure Pharma INC. | $119.51 | 2020 | |
| Abbott Laboratories | $112.32 | 2019-2024 | Diamondback Peripheral |
| Janssen Pharmaceuticals, INC | $110.06 | 2019-2024 | Xarelto |
| Venclose INC. | $106.67 | 2020 | |
| Amgen INC. | $84.53 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $81.37 | 2021-2024 | Venclose Maven Catheter |
| Pfizer INC. | $80.33 | 2020-2021 | |
| Boston Scientific Corporation | $72.11 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $53.03 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.90 | 2020 | |
| Inspire Medical Systems, INC. | $37.98 | 2024 | Inspire |
| Bardy Diagnostics, INC. | $31.77 | 2020 | |
| Esperion Therapeutics, INC. | $31.20 | 2020 | |
| Avinger INC. | $20.92 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $20.59 | 2022 | |
| Abiomed | $14.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Slusky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.